Effect of SDZ MRL 953 on the survival of mice with advanced sepsis that cannot be cured by antibiotics alone.
Stimulation of nonspecific immunity as an additional modality for therapy of sepsis that cannot be cured by antibiotics alone was investigated. SDZ MRL 953, a novel monosaccharidic lipid A analog as a prototype immunostimulant, and cefotaxime or gentamicin were administered to normal or myelosuppres...
Spremljeno u:
| Izdano u: | Antimicrob Agents Chemother |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society for Microbiology (ASM)
1991
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245040/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2039201/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.3.506 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|